Connect with

Friday 19 April 2024

Peer Reviewed

Feature Article Rheumatology

Update on spondyloarthritis

Mark Reed, Lionel Schachna

Recent articles on:
Arthritis

Crystal arthritis – managing gout and calcium pyrophosphate deposition disease

Psoriatic arthritis: how early recognition helps management

Juvenile idiopathic arthritis – a new outlook

Janus kinase inhibitors in inflammatory arthritis: what the GP needs to know

New targeted therapies for rheumatoid arthritis

Recent articles on:
Spinal diseases

Ankylosing spondylitis: new insights into an old disease

A cause of cauda equina syndrome

Severe back pain – is it a spinal abscess?

The diagnosis and management of ankylosing spondylitis

Diagnosing DISH

Abstract

Differentiating spondyloarthritides from more common mechanical back disorders is the major challenge in general practice.

Key Points

Spondyloarthritis occurs in 2 to 3% of the population and can cause significant long term disability.
Early diagnosis of spondyloarthritis is critical in the era of effective biological therapies.
A detailed but focused history is essential in identifying early spondyloarthritis, when examination findings and radiographs may be normal.
Traditional disease modifying antirheumatic drugs (DMARDs) are less effective in spondyloarthritis than in rheumatoid arthritis.
Tumour necrosis factor (TNF) inhibitors have revolutionised the management of spondyloarthritis.